KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Non-Current Debt (2018 - 2024)

Historic Non-Current Debt for BioNTech SE (BNTX) over the last 7 years, with Q4 2024 value amounting to $50.1 million.

  • BioNTech SE's Non-Current Debt rose 2005.12% to $50.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $50.1 million, marking a year-over-year increase of 2005.12%. This contributed to the annual value of $50.1 million for FY2024, which is 2005.12% up from last year.
  • Per BioNTech SE's latest filing, its Non-Current Debt stood at $50.1 million for Q4 2024, which was up 2005.12% from $41.7 million recorded in Q4 2023.
  • In the past 5 years, BioNTech SE's Non-Current Debt registered a high of $275.4 million during Q4 2020, and its lowest value of $6.2 million during Q4 2022.
  • In the last 5 years, BioNTech SE's Non-Current Debt had a median value of $50.1 million in 2024 and averaged $115.4 million.
  • In the last 5 years, BioNTech SE's Non-Current Debt crashed by 9693.85% in 2022 and then soared by 57078.67% in 2023.
  • Quarter analysis of 5 years shows BioNTech SE's Non-Current Debt stood at $275.4 million in 2020, then dropped by 26.19% to $203.3 million in 2021, then plummeted by 96.94% to $6.2 million in 2022, then soared by 570.79% to $41.7 million in 2023, then rose by 20.05% to $50.1 million in 2024.
  • Its last three reported values are $50.1 million in Q4 2024, $41.7 million for Q4 2023, and $6.2 million during Q4 2022.